CONCIEO PHARMA, LLC
Live / Registered — Registered (as of 15 Aug 2023)
What this means for you
Registered since 15 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97098251
- Registration number
- 7140342
- Mark type
- Stylized text
- Filed
- 28 Oct 2021
- Published for opposition
- 13 Sept 2022
- Registered
- 15 Aug 2023
- Attorney of record
- Cecilia S. Barnes
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, infectious diseases, autoimmune disorders, cardiovascular diseases, blood disorders, neurologic disorders, skin diseases, musculoskeletal disorders, genetic disorders, digestive disorders, diabetes-related conditions, eye conditions, viral, and transplants
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune disorders, cardiovascular diseases, blood disorders, neurologic disorders, skin diseases, musculoskeletal disorders, genetic disorders, digestive disorders, diabetes-related conditions, eye conditions, viral, and transplants
- Class 040 — Treatment of materials: Custom manufacture of active pharmaceutical ingredients, chemical compounds, and biologicals for pharmaceutical preparations
Owner
- Concieo Pharma, LLC, Memphis, TN, US
- Concieo Pharma, LLC, Memphis, TN, US
- Concieo Pharma, LLC, Memphis, TN, US
Prosecution history
- 15 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
- 12 Jul 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Jul 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Jul 2023 — EXAMINER'S AMENDMENT ENTERED
- 11 Jul 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 Jul 2023 — EXAMINERS AMENDMENT E-MAILED
- 11 Jul 2023 — SU-EXAMINER'S AMENDMENT WRITTEN
- 26 Jun 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Jun 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Jun 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Jun 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Jun 2023 — NON-FINAL ACTION E-MAILED
- 12 Jun 2023 — SU - NON-FINAL ACTION - WRITTEN
- 17 May 2023 — STATEMENT OF USE PROCESSING COMPLETE